美股異動丨秦淮數據(CD.US)盤前大漲近14% 據悉收到來自業內競爭對手的初步收購興趣
格隆匯4月22日丨秦淮數據(CD.US)盤前大漲近14%,報4.98美元。彭博引述知情人士消息,由私募股權公司Bain Capital支持的秦淮數據,已接收到業內其他公司的初步收購意向,其中萬國數據 (GDS.US)正考慮與秦淮數據合併,而其他競爭對手例如私募股權公司殷拓支持的EdgeConneX,亦可能會考慮競購。知情人士稱,秦淮數據董事會尚未考慮任何提議,Bain Capital亦可能決定推遲一切交易,直到秦淮數據的股價反彈。而相關討論亦處初步階段,沒有啟動正式的出售程序。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.